Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Anti-FGFR3 antibodies and methods using same
Software execution management apparatus, method, and computer-readable medium thereof
Packaging sleeve
Flood protection apparatus and container data center including the same
Clock face
Asynchronous loading of scripts in web pages
  Randomly Featured Patents
Process and apparatus for the direct and continuous modification of polymer melts
Method for synchronizing redundant operation of coupled data processing systems following an interrupt event or in response to an internal command
Hairspray shield
Backup system for electronic fuel injection control system
Integrated memory circuit having complementary bit line charging
Display circuit adapted for a display device and display device
Position sensing device
Apparatus and method for thermal cutting of a workpiece
Tape slitter
Inflatable internal pipe obturator with hardenable core